HIDAVEL
Dead / Abandoned — Abandoned — no statement of use filed (as of 02 Nov 2009)
What this means for you
This application is over — abandoned 02 Nov 2009. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 77398468
- Mark type
- Stylized text
- Filed
- 15 Feb 2008
- Published for opposition
- 08 Jul 2008
- Abandoned
- 02 Nov 2009
- Attorney of record
- Camille M. Miller
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals for the treatment of cancer, diabetes, inflammation, cardiovascular disease and neurodegenerative disease
Owner
- CELGENE CORPORATION, SUMMIT, NJ, US
- Pharmion Corporation, Boulder, CO, US
- Pharmion Corporation, Boulder, CO, US
Prosecution history
- 02 Nov 2009 — ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
- 02 Nov 2009 — ABANDONMENT - NO USE STATEMENT FILED
- 09 Feb 2009 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 09 Feb 2009 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 05 Feb 2009 — TEAS POST PUBLICATION AMENDMENT RECEIVED
- 26 Jan 2009 — SOU EXTENSION 1 GRANTED
- 26 Jan 2009 — SOU EXTENSION 1 FILED
- 26 Jan 2009 — SOU TEAS EXTENSION RECEIVED
- 30 Sept 2008 — NOA MAILED - SOU REQUIRED FROM APPLICANT
- 08 Jul 2008 — PUBLISHED FOR OPPOSITION
- 18 Jun 2008 — NOTICE OF PUBLICATION
- 30 May 2008 — LAW OFFICE PUBLICATION REVIEW COMPLETED
- 29 May 2008 — ASSIGNED TO LIE
- 29 May 2008 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 28 May 2008 — ASSIGNED TO EXAMINER